Purchases and Sales Made in Q1 2025 in Phathom Pharmaceuticals, Inc. (PHAT)
This table provides information about the institutional ownership of Phathom Pharmaceuticals, Inc. (PHAT) during Q1 2025. The information is specifically focused on institutions that hold shares of Phathom Pharmaceuticals, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 15, 2025
Q1 2025
|
State Street Corp
Boston, MA |
SELL
|
- |
-139K- 13.33% |
$585K - $1.07M
|
901K
$7.9M
|
|
|
May 09, 2025
Q1 2025
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-224K- 54.43% |
$947K - $1.74M
|
188K
$1.65M
|
|
|
May 15, 2025
Q1 2025
|
Woodline Partners LP
San Francisco, CA |
SELL
|
- |
-250K- 24.96% |
$1.06M - $1.94M
|
752K
$6.59M
|
|
|
May 15, 2025
Q1 2025
|
Two Sigma Investments, LP
New York, NY |
SELL
|
- |
-388K- 79.97% |
$1.64M - $3.01M
|
97.3K
$854K
|
|
|
May 15, 2025
Q1 2025
|
Avidity Partners Management LP
Dallas, TX |
SELL
|
- |
-590K- 42.45% |
$2.49M - $4.57M
|
800K
$7.02M
|